Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionDual inhibitor of DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR; FRAP; RAFT1)
Molecular Target DNA-dependent protein kinase (DNA-PK) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today